ORIC PHARMACEUTICALS INC. - COMMON STOCK

ORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Investor Conference

25 4月 2023 16:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting

18 4月 2023 16:15:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates

16 3月 2023 16:05:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Announces Multiple Presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting

14 3月 2023 16:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare Conference

06 3月 2023 16:15:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 2月 2023 16:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

01 2月 2023 16:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones

09 1月 2023 08:00:01 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

03 1月 2023 16:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Announces Clinical Development Collaboration with Pfizer for ORIC-533 in Multiple Myeloma and Concurrent $25 Million Equity Investment by Pfizer

21 12月 2022 17:48:37 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Presents Preclinical Data Demonstrating ORIC-533 as a Potential Best-in-Class CD73 Inhibitor at the 64th American Society of Hematology (ASH) Annual Meeting

13 12月 2022 08:00:01 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present at the Jefferies London Healthcare Conference

08 11月 2022 16:10:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Update

07 11月 2022 16:05:01 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present Preclinical Data on CD73 Inhibitor Program in Multiple Myeloma at the 64th American Society of Hematology (ASH) Annual Meeting

03 11月 2022 09:00:01 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

07 10月 2022 16:30:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

01 9月 2022 16:15:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update

11 8月 2022 16:05:01 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present at the Jefferies Healthcare Conference

02 6月 2022 16:10:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

17 5月 2022 16:10:00 条件 Nasdaq GlobeNewswire

ORIC Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update

09 5月 2022 16:05:03 条件 Nasdaq GlobeNewswire